A 16 week study to evaluate the effect on insulin sensitivity of valsartan and hydrochlorothiazide combined and alone, in patients with metabolic syndrome

Trial Profile

A 16 week study to evaluate the effect on insulin sensitivity of valsartan and hydrochlorothiazide combined and alone, in patients with metabolic syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Nov 2016

At a glance

  • Drugs Hydrochlorothiazide (Primary) ; Valsartan (Primary) ; Valsartan/hydrochlorothiazide (Primary)
  • Indications Hypertension; Metabolic syndrome
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms MADE-ITT
  • Sponsors Novartis
  • Most Recent Events

    • 21 Sep 2008 Actual end date (1 Mar 2006) added as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 May 2007 Blood pressure results presented at the 22nd Annual Scientific Meeting of the American Society of Hypertension (ASH 2007).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top